The Jerusalem Post reports on a company established by a Weizmann Institute alum, Nir Erez, who left a job in big pharma to find a way to help cancer sufferers. His firm, Trial-In Pharma, connects patients to 20,000 clinical trials and compassionate use treatments worldwide.
March 24, 2019
On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically - in the field of cancer research. This is a milestone in the history of these two institutes that have been working together for 15 years, particularly in the field of biophysics.
March 22, 2019
Education Minister Naftali Bennett announced Wednesday that Professor Adi Kimchi of the Weizmann Institute of Science is this year’s winner of the Israel Prize for research in life sciences. Kimchi heads a lab that studies the complex processes of programmed death in living cells. The prize selection committee noted Kimchi’s pioneering work in isolating genes involved in cells’ self-destruction, a process that, among other things, helps the body suppress cancer development.
March 20, 2019
An anti-cancer therapy that has been developed by scientists at the Weizmann Institute of Technology will get a $10 million investment from a South Korean biopharmaceutical company that is traded on the Korea Stock Exchange. This is the Korean firm’s first investment in an Israeli venture, the Weizmann Institute said in a statement.
March 20, 2019
The Jerusalem Post reports on plant sciences research that was shared by American Committee CEO Dave Doneson in the second episode of his video series, “Weizmann in Focus.”
March 19, 2019
Berkeley Lab biochemist Mina Bissell has received two significant awards – including the 2019 Weizmann Women & Science Award – in recognition of her contributions to breast cancer biology and medicine.
March 19, 2019
The universal flu vaccine startup BiondVax – based on technology developed by Weizmann’s Prof. Ruth Arnon – is successfully advancing through clinical trials.
March 19, 2019
A team of scientists from the Weizmann Institute of Science and SpaceIL engineers have identified the site for Israel's Beresheet spacecraft's lunar landing. According to a release disseminated by the Weizmann Institute, the chosen site was selected by Prof. Oded Aharonson of the Weizmann Institute and Prof. Jim Head of Brown University. It is located in the northeastern part of Mare Serenitatis, a few hundreds of miles east of the Apollo 15 landing site and a similar distance northwest from the Apollo 17 site.
March 19, 2019
Psychology Today covers new research by the lab of Prof. Noam Sobel, which found that breathing in while addressing a problem helps us solve the matter more quickly. It also sheds light on the evolution of the brain and other senses.
March 17, 2019
©2019 American Committee for the Weizmann Institute of Science
